Durable Medical Equipment Manufacturer Agrees To Pay $2.715 Million To Resolve False Claims Allegations
Innovative Therapies, Inc. ("ITI") and its ultimate parent company Cardinal Health, Inc. ("Cardinal") have agreed to pay $2.715 million to settle False Claims Act allegations, announced Jack Smith, Acting United States Attorney for the Middle District of Tennessee. The settlement concerns conduct initiated by ITI before being purchased by Cardinal in August 2014 and resolves a qui tam action filed by a whistleblower in May 2015.
- Date:June 29, 2017
- Agency:U.S. Attorney
- Criminal and Civil Actions